| Code | 7674D | ||||||||
| MA number | 09/0142/21-S | ||||||||
| Product Form: | tbl mnd 36x625 mg/73,5 mg/150 mg (strip LDPE/Al) | ||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||
| ATC: |
|
||||||||
| Shelf life: | 36 | ||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 26.05.2021 |
| Validity: | 26.05.2026 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| SPC: |
SPC_Rennie Plus 625 mg_73,5 mg_150 mg žuvacie tablety_05_2021.pdf
|
| PIL: |
PIL_Rennie Plus 625 mg_73,5 mg_150 mg žuvacie tablety_05_2021.pdf
|
| Safety feature | No |
| Data update: | 28.05.2021 |
